The yield of procalcitonin and Interleukin-6 in predicting intraamniotic infection in the presence of intrapartum fever: A pilot study

PLoS One. 2023 Jul 12;18(7):e0288537. doi: 10.1371/journal.pone.0288537. eCollection 2023.

Abstract

Intrapartum fever (IF) accompanied by either maternal or foetal tachycardia, elevated WBC, or purulent discharge is classified as "suspected triple 1", the hallmark of intraamniotic infection (IAI). Poor specificity of the clinical diagnosis of IAI results, in retrospect, in the unnecessary treatment of most parturients and neonates. We studied the yield of specific acute phase reactants (APRs): procalcitonin, CRP, IL-6, in detecting bacterial IAI among parturients classified as "suspected triple 1" (cases) compared to afebrile parturients (controls). Procalcitonin, CRP, and IL-6 were all significantly elevated in the cases compared to the controls, yet this by itself was not sufficient for an additive effect in detecting a bacterial infection among parturients clinically diagnosed with "suspected triple 1", as demonstrated by the poor area under the receiver operating characteristic curve of all three APRs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Proteins
  • Amnion* / microbiology
  • Bacterial Infections* / diagnosis
  • Female
  • Fever* / diagnosis
  • Humans
  • Infant, Newborn
  • Interleukin-6*
  • Pilot Projects
  • Pregnancy
  • Procalcitonin*

Substances

  • Acute-Phase Proteins
  • Interleukin-6
  • Procalcitonin

Grants and funding

ZE received funding for this study from Roche. Funder provided the lab kits for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.roche.com/.